The lysosomal cysteine proteinase cathepsin B is synthesized in cultured human hepatoma HepG2 cells as an inactive 44 kDa precursor and subsequently processed to the mature single-chain enzyme with a molecular mass of 33 kDa. Intralysosomal conversion into the two-chain form results in subunits of 27 kDa, 24 kDa (heavy chain) and 5 kDa (light chain). Enzymic deglycosylation reveals that the 27 kDa polypeptide is the glycosylated variant of the carbohydrate-free 24 kDa heavy-chain form. The intracellular transport to the lysosomes is dependent upon mannose 6-phosphatecontaining N-linked oligosaccharides. Receptor-mediated endocytosis of human skin-fibroblast-derived procathepsin B by HepG2 cells resulted in processed molecular forms that are not distinguishable from endogenous cathepsin B, thus favouring rather a cell-type-specific processing than structural differences due to the source of the proenzyme. The conversion step of single-chain cathepsin B into the two-chain enzyme is inhibited in vivo by the irreversible cysteineproteinase inhibitors Z-Phe-Ala-CHN2 and, albeit weaker, Z-Phe-Phe-CHN2. Both substances have no effect on the activation of procathepsin B to the mature enzyme. The carbohydrate moiety of cathepsin B exerts no significant influence on the stability and the enzymic activity of the enzyme.
INTRODUCTION
The role of the endogenous cysteine proteinases cathepsins B, H and L in general intracellular protein turnover is well documented (Shaw & Dean, 1980; Grinde, 1983) . Immunocytochemical localization demonstrated that these enzymes reside in the lysosomes (Mort et al., 1981b; Ii et al., 1985) . As is typical for soluble lysosomal enzymes , the intracellular targeting to this organelle is dependent on the creation of the mannose 6-phosphate recognition marker (Hanewinkel et al., 1987; Mason et al., 1987; Nishimura et al., 1988b) . As lysosomal proteinases are synthesized as latent procathepsins, proteolytic maturation to the active enzymes occurs either in an acidic prelysosomal compartment, as reported for cathepsin D (Gieselmann et al., 1983) , or as an early event in the lysosomes (Nishimura & Kato, 1987) . Only a small amount of the proenzymes is secreted by default into the extracellular fluid (Hanewinkel et al., 1987; Reilly et al., 1989) . However, the secretion of active and activatable latent high-molecular-mass forms of cathepsins B and L can be elevated as response to viral transformation (Mason et al., 1987; Achkar et al., 1990 ), malignant dedifferentiation (Mort et al., 1981a; Recklies & Mort, 1982) , growth factors (Prence et al., 1990) or inflammation (Mort et al., 1984; Buttle et al., 1988) . Increased transcription of the cathepsin B gene probably accounts for the elevated extracellular concentration of this proteinase in mouse melanomas (Moin et al., 1989; Qian et al., 1989) . In the case of Moloneymouse-sarcoma-virus-transformed Balb/c 3T3 fibroblasts the enhanced secretion of procathepsins B and L as well as other lysosomal enzymes has been correlated to the lack or the malfunction of mannose 6-phosphate receptors on the cell surface (Achkar et al., 1990) . Extracellular procathepsin L secreted by Kirsten-virus-transformed mouse NIH 3T3 fibroblasts was reported to be a consequence of a low-affinity interaction with the endogenous mannose 6-phosphate receptors Lazzarino & Gabel, 1990) . In neoplastic tissues the enzymes were reported to occur associated with the plasma membrane (Sloane et al., 1987; Rozhin et al., 1989) .
The interrelationship of active and latent high-molecular-mass cathepsin B isoenzymes is not well understood (Mort & Recklies, 1986) . On the other hand, the intracellular processes resulting in activation of the proenzyme are also not yet elucidated (Nishimura et al., 1990; Felleisen & Klinkert, 1990 ). The observed microheterogeneity of endogenous cathepsin B in various tissues was not further characterized, although analyses of cloned cDNAs revealed no striking differences (Fong et al., 1986; Chan et al., 1986) . Therefore the role of the endogenous processing machinery and of the mode of glycosylation in the existence of different molecular forms ofthe enzyme remains to be established.
In the present paper we report on the interrelationship of cathepsin B isoenzymes in human hepatoma HepG2 cells and provide evidence for the existence of cell-type specific processing events. The role of the carbohydrate moiety of cathepsin B (Takahashi et al., 1984) Knight (1980) . Z-Phe-Ala-CHN2 and Z-Phe-Phe-CHN2 were kindly provided by Dr. E. Shaw (Friedrich-Miescher-Institut, Basel, Switzerland) . Gly-Phe-Gly-Sc was prepared and coupled to CH-Sepharose 4B (Pharmacia, Uppsala, Sweden) as described by Rich et al. (1986) . Peptide: N-glycosidase F (PNGase F) was supplied by Genzyme (Boston, MA, U.S.A.). The human hepatoma cell line HepG2 was obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). Post-mortem human livers obtained by autopsy within 20 h of death were immediately frozen in liquid N2 and stored at -70°C until use. Human liver cathepsin B was purified to homogeneity by the method of Rich et al. (1986) and coupled to CNBr-activated Sepharose 4B (Pharmacia) at a density of 2.6 mg/ml of gel. The preparation of an antiserum in rabbits against human liver cathepsin B was reported previously (Hanewinkel et al., 1987) . Goat anti-(rabbit IgG) immunoglobulins conjugated to horseradish peroxidase were obtained from Accurate (Westbury, NY, U.S.A.). All other reagents were of the best quality grade available.
Cultivation and labelling of cells
Human diploid skin fibroblasts were maintained in Eagle's minimal essential medium as described by Cantz et al. (1972) . HepG2 cells were grown analogously. Metabolic labelling of confluent cell layers was done according to the procedure of Hanewinkel et al. (1987) .
Preparation of cell and medium extracts and immune precipitation of cathepsin B Non-labelled cells were extracted for analysis by enzymic deglycosylation and subsequent immunoblotting as described previously (Hanewinkel et al., 1987) .
Conditioned media were obtained by culturing the respective cell layers for 24 h in serum-free medium (Waymouth MAB 87/3; composition as outlined in the Gibco catalogue) supplemented with 4 ,tg of human serum transferrin/ml and 30 nmsodium selenite in the presence of 10 mM-NH4Cl. Each medium was centrifuged at 400 g for 5 min to remove cell debris, and the supernatant was freeze-dried. The residue was solubilized in 20 mM-sodium phosphate buffer, pH 6.5 (one-tenth of the original volume), and dialysed twice for 2 h against 2 litres of the same buffer. The non-diffusible material was freeze-dried, dissolved in 20 mM-sodium phosphate buffer, pH 6.5 (one-thirtieth of the original volume), dialysed as described above and stored frozen at -20 'C. NH4CI-induced secretions after incubation in the presence of 9 ,ug of tunicamycin/ml were treated analogously.
The extraction and immune precipitation of cathepsin B from labelled cell layers was done as reported previously (Hanewinkel et al., 1987) , with the following modifications. After labelling, the cell layer of a 25 cm2 flask was washed twice with Hanks balanced salt solution and extracted with 200,1 of SDS/PAGE sample buffer (Laemmli, 1970) without glycerol, containing proteinase inhibitors (2 mM-EDTA, 1 mM-phenylmethanesulphonyl fluoride, 1 ,/M-leupeptin and 10 ,tg of aprotinin/ml), for 10 min at room temperature. An extract of the medium was prepared by precipitation with 70%-saturated (NH4)2SO4 and solubilization of the precipitate in 200 /tl of the buffer used for cell extraction. The extracts were heated at 95 'C for 5 min and then treated with 26 mM-iodoacetamide for 30 min at room temperature. Before immune precipitation, the extracts were diluted 10-fold with buffer A [50 mM-Tris/HCl buffer, pH 8.3, containing 0.15 M-NaCl, 1 % (w/v) Triton X-100, 1 % (w/v) sodium deoxycholate, 0.25 % (w/v) SDS, 2 mM-EDTA, 1 mmphenylmethanesulphonyl fluoride, 10 ,g of aprotinin/ml and 5 mg of BSA/ml] and centrifuged at 10000 g for 10 min at room temperature. The supernatant was mixed end-over-end with preimmune-IgG-coated Protein A-Sepharose (4 mg/25 cm2 flask) for 2 h at 4 'C. After centrifugation (10000 g for 3 min) the supernatant was transferred to a tube containing 10 mg of Protein A-Sepharose coated with IgG of 50 ,ul of antiserum. The suspension was shaken overnight at 4 'C and centrifuged as above, and the pellet was washed with three 1 ml portions of buffer A without BSA. After further washing steps with 2 x 1 ml of 50 mM-Tris/HCl buffer, pH 8.3, containing 1.5 M-NaCl and 2 x 1 ml of 10 mM-Tris/HCI buffer, pH 6.8, the immune precipitated polypeptides were solubilized in 70,ul of 1.25-foldconcentrated SDS/PAGE sample buffer, heated at 95 'C for 5 min and analysed by SDS/PAGE and fluorography.
Endocytosis experiments
NH4Cl-induced [35S]methionine-labelled secretions from human fibroblasts or HepG2 cells were incubated with the respective recipient cell lines as described previously . Extracts of the recipient cells were analysed by immune precipitation of cathepsin B and subsequent SDS/PAGE and fluorography.
Enzymic deglycosylation
Unlabelled cell extracts or medium proteins were deglycosylated after denaturation with SDS and 2-mercaptoethanol by treatment with 2 munits of PNGase F for 16 h at 37 'C as described previously (Hanewinkel et al., 1987) . Subsequent to analysis by SDS/PAGE, cathepsin B polypeptides were detected by immunoblotting.
For deglycosylation of crude native procathepsin B, 50 ,tg of total protein from HepG2-conditioned medium obtained after incubation in the presence of 10 mM-NH4CI was precipitated with 5 vol. of acetone for 30 min at 0 'C. After centrifugation (13 000 g for 0 min), the pellet was dried and solubilized in 100 mM-sodium phosphate buffer, pH 7.2, containing 1O mm-1,10-phenanthroline and 0.2 % (w/v) Nonidet P-40. The samples were incubated for 8 h at 37 'C with addition of 1 munit of PNGase F after 0, 2, 4 and 6 h.
Assay of the latent activity of procathepsin B Activation of latent procathepsin B in vitro was achieved by the procedure of Mort et al. (1981a) with minor modifications. A 40,ul portion of proenzyme solution (eventually diluted with 0.2 mg of BSA/ml) was incubated with 30 ,ul of pepsin (250 ,ug/ml) in 0.1 M-sodium formate buffer, pH 3.5, for 30 min at 37 'C. The pre-activation step was stopped by addition of 230 ,ul of activation buffer (2.7 mM-cysteine in 88 mm-KH2PO4/12 mM-Na2HPO4/1.33 mM-EDTA buffer, pH 6.8), and enzymic activity was determined against Z-Arg-Arg-NHNap as described by Barrett & Kirschke (1981) .
Other methods SDS/PAGE with a total monomer concentration of 12.5 % (w/v) was performed according to the procedure of Laemmli (1970) with minor modifications as outlined by Hasilik & Neufeld (1980) . Detection of labelled polypeptides was done by fluorography as described by Bonner & Laskey (1974) .
Transfer of proteins to nitrocellulose sheets was done by the procedure of Towbin et al. (1979) . The membranes were incubated with affinity-purified rabbit anti-(human liver cathepsin B) antibodies (3 usg/ml), prepared by immunoaffinity chromatography on cathepsin B-Sepharose as described in Johnstone & Thorpe (1982) , with the use of 3 M-KSCN in 0.5 M-ammonium chloride buffer, pH 10.0, for elution. Subsequent detection of cathepsin B-related polypeptides was performed by the use of goat anti-(rabbit IgG) immunoglobulins conjugated to horseradish peroxidase as described by Theisen et al. (1986 (Fig. la) . Overdevelopment led to the additional appearance of the 33 kDa single-chain enzyme (Fig. lb) . On omission of reduction before electrophoresis, the 24 kDa and 27 kDa proteins could be identified as heavy-chain variants of two-chain cathepsin B (results not shown). Treatment with PNGase F reveals the different electrophoretic mobilities of the heavy-chain polypeptides to be due to N-glycosidically linked oligosaccharides.
Biosynthesis of cathepsin B in human hepatoma cells
Metabolic labelling of HepG2 cells for 1 h identifies a protein with molecular mass 44 kDa to be the first detectable translation product of cathepsin B mRNA (Fig. 2) . This inactive precursor is converted during 5 h into the single-chain enzyme (molecular mass 33 kDa) and after prolonged chase for 24-44 h into the two-chain forms with the large subunits of 27 and 24 kDa. The 5 kDa light chain cannot be identified in the gel system used. The ratio between glycosylated and deglycosylated heavy chains does not vary significantly during prolonged incubations, suggesting no fundamental difference of these two polypeptides concerning their half-time. About 5-10 % of the newly made procathepsin B is secreted into the culture medium. Addition of the lysosomotropic base NH4Cl or treatment with the N-glycosylation inhibitor tunicamycin resulted in more than 95 % secretion (results not shown). As already observed for human skin fibroblasts, the final processing step of the single-chain into the two-chain forms could be inhibited in vivo by leupeptin, a reversible serine-proteinase and cysteine-proteinase inhibitor (results not shown). Incubation of the cell layers with the irreversible cysteine-proteinase inhibitor Z-Phe-Ala-CHN2 could also effectively block this conversion (Fig. 3) 
DISCUSSION
The molecular forms of cathepsin B in human skin fibroblasts (Hanewinkel et al., 1987) exhibit differences as compared with the isoenzymes detectable in human liver (Hanewinkel et al., 1987) , rat liver (Nishimura & Kato, 1987) and rat hepatocytes (Nishimura et al., 1988b) . Cloned cDNAs from various human tissues revealed no striking differences (Chan et al., 1986; Fong et al., 1986) , although the existence as single-chain as well as twochain enzyme is well established (Takio et al., 1983 (Hanewinkel et al., 1987) . Human hepatoma procathepsin B appears to behave identically with the precursor from human skin fibroblasts (Hanewinkel et al., 1987) . The intracellular sorting as well as the uptake of exogenous proenzyme by receptor-mediated endocytosis is dependent on the creation of the mannose 6-phosphate recognition marker. The final processing product in HepG2 cells is mainly the two-chain enzyme. We could demonstrate that the heavy-chain subunit exists glycosylated as well as devoid of any N-linked oligosaccharides, probably as a consequence of the action of lysosomal endoglycosidases. Removal of the carbohydrate moiety obviously does not affect the stability against proteolytic degradation in vivo. In addition, these results explain the reported carbohydrate structures for mature cathepsin B from rat liver and pig spleen (Takahashi et al., 1984; Taniguchi et al., 1985) . The conversion into the two-chain form occurs in the lysosomes and seems to be a cell-type-specific event. Receptormediated endocytosis of human skin-fibroblast-derived procathepsin B by HepG2 cells or vice versa yields processed mature forms indistinguishable from the endogenous enzyme, suggesting the existence of specific endogenous processing machineries rather than structural differences due to the source of the proenzyme. These results are in good agreement with the processing of exogenous mouse procathepsin L by Chinesehamster ovary cells (Salminen & Gottesman, 1990) . In addition, these authors suggested autocatalytic processing events, as the specific cysteine-proteinase inhibitors Z-Phe-Ala-CHN and ZPhe-Phe-CHN2 (Shaw et al., 1983) could inhibit the conversion 1992 of single-chain cathepsin L into the two-chain form. In human hepatoma cells Z-Phe-Ala-CHN2 effectively blocks the conversion of single-chain cathepsin B into the two-chain enzyme, whereas Z-Phe-Phe-CHN2 exerts less influence on cathepsin B processing. However, to identify the cysteine proteinase(s) involved, highly specific inhibitors would be required. The proteolytic maturation of the latent proenzyme was affected neither by Z-Phe-Ala-CHN2 nor by Z-Phe-Phe-CHN2' Heterogeneity of glycoproteins obtained from different tissues has been attributed frequently to cell-type-specific variations in glycosylation (e.g. Rademacher et al., 1988) . As loss of the catalytic properties and enhanced susceptibility to general proteolytic attack could be consequences of removal of the carbohydrate moiety, the influence of N-linked oligosaccharides on the stability and the activity of cathepsin B was assessed. For experimental reasons, we had to use native latent procathepsin B for these studies and subsequently activate the proenzyme in vitro by digestion with pepsin (Mort et al., 1983) . Removal of Nlinked oligosaccharides results neither in loss of enzymic activity, as already shown for cathepsin L , nor in a diminished stability against proteolytic degradation. Therefore the existence of cell-type-specific lysosomal endoglycosidases may explain the variation in the ratio between glycosylated and carbohydrate-free two-chain enzyme as observed in various human tissues and cell lines (L. Mach, C. Ballaun & J. Glossl, unpublished work), but does not influence the process of conversion of single-chain cathepsin B into the two chains. In addition, lack of glycosylation therefore cannot explain how expression of cathepsin B cDNAs in Escherichia coli does not yield active enzyme (Mort et al., 1988) . Similar results have been reported for the production of recombinant cathepsin L and cathepsin D in E. coli, where only excessive denaturation and renaturation procedures gave small amounts of enzymically active proteins Conner & Udey, 1990) .
Besides the insight we obtained into the molecular processes involved in the late maturation steps of lysosomal cathepsin B, we have no information on the activating enzyme in vivo. Various low-molecular mass inhibitors already used successfully for the analysis of processing in vivo (Nishimura et al., 1988a; Hara et al., 1988) either proved to have toxic effects on human hepatoma cells or failed to penetrate these cells (K. Stuwe & J. Gl6ssl, unpublished work). Studies performed in vitro indicated either the dependence of activation on the action of an aspartic proteinase (Nishimura et al., 1990) or autoactivation of cathepsin B itself (Felleisen & Klinkert, 1990) .
